Labcorp reported $14.1B of revenue over the trailing twelve months, +7.3% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $14.1B (to Q1 2026). Net Income: $942M, trailing twelve months to Q1 2026. Free Cash Flow: $1.38B, trailing twelve months to Q1 2026. Op Margin: 10%, trailing twelve months to Q1 2026.

LHLabcorp

HealthcareUSD

$335.71

$244.6952 weeks$339.57

LH as reported

Labcorp reported $14.1B of revenue over the trailing twelve months, +7.3% on the year before. 11 reported series are charted on this page, each one as filed.

$14.1B

Revenue, trailing twelve months · to Q1 2026 · +7.3% against the twelve months before

Net Income: $942M
Net Income · +29% year on year · trailing twelve months to Q1 2026
Free Cash Flow: $1.38B
Free Cash Flow · +20% year on year · trailing twelve months to Q1 2026
Op Margin: 10%
Op Margin · trailing twelve months to Q1 2026

Every series Ryufin has for LH, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$14.1B	+7.3%	Q1 2026
Net Income	$942M	+29%	Q1 2026
EPS	$11.29	+30%	Q1 2026
Gross Margin	29%	n/a	Q1 2026
Op Margin	10%	n/a	Q1 2026
Net Margin	6.7%	n/a	Q1 2026
ROE	9.9%	n/a	Q1 2026
ROA	4.7%	n/a	Q1 2026
ROIC	7.8%	n/a	Q1 2026
Free Cash Flow	$1.38B	+20%	Q1 2026
P/E	29.7	n/a	today